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Abstract
Metaplastic breast carcinoma (MBC) is a rare neoplasm containing a mixture of epithelial and
mesenchymal elements. The epithelial component is usually ductal carcinoma but may include other
variants of breast carcinomas including squamous carcinoma and osteogenic sarcoma. There is a
relative paucity of data regarding such tumours. Metaplastic carcinoma carries a prognosis not
dissimilar to that of comparable ductal carcinoma. This is the case of a 57 year old patient with
MBC presenting with a breast abscess. A thorough literature search has not revealed any previous
reports of MBC presenting as a breast abscess.
Background
Metaplastic breast carcinoma (MBC) is a rare neoplasm
containing a mixture of malignant epithelial and mesen-
chymal elements. The epithelial component is usually
ductal carcinoma but may include other variants of breast
carcinomas including squamous carcinoma. The mesen-
chymal component is usually composed of non-specific
malignant spindle cells but may include differentiated sar-
comas including fibrosarcoma, leiomyosarcoma and oste-
ogenic sarcoma [1]. It represents as little as 0.02% of all
breast malignancies [2]. There is a relative paucity of data
regarding treatment options and prognosis. A thorough
literature search (PUBMED and MEDLINE) has revealed a
number of case reports where such tumours have pre-
sented as a breast lump, but this is the first report of MBC
presenting as a breast abscess.
Case history
A 57 year-old postmenopausal Caucasian woman with no
significant past medical history presented with a four
week history of rapid swelling, pain and erythema in her
right breast. There was no history of trauma, and symp-
toms had not settled with oral antibiotics. She had never
taken hormone replacement therapy. She had a low grade
pyrexia, but was otherwise systemically well.
On examination, her entire right breast was erythematous,
warm and swollen, with fluctuance and pointing in the
outer lower quadrant. Otherwise, the breast was firm and
non-fluctuant. The right nipple had been inverted since
her symptoms began. Initial investigations revealed raised
inflammatory markers and a neutrophillia. She also had a
raised alkaline phosphatase of 615.
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An initial diagnosis of a breast abscess was made, possibly
secondary to an inflammatory carcinoma, and needle
aspiration was attempted, although this did not yield pus.
She was commenced on intravenous antibiotics and an
ultrasound was arranged, which showed multiple locula-
tions containing thick pus.
As the patient was in considerable distress, she underwent
incision and drainage of this collection. The abscess was
drained, although the cavity wall was noted to be suspi-
cious and open biopsies were taken. Histology showed
"metaplastic carcinoma with features of osteogenic sar-
coma." She then underwent staging CT and bone scans.
CT demonstrated multiple small calcified nodules in both
lungs consistent with metastatic deposits. Bone scan did
not show any skeletal lesions.
The patient underwent three cycles of neoadjuvant chem-
otherapy with ifosphamide and adriamycin, but this was
poorly tolerated, and had only a modest effect on the pri-
mary tumour and metastatic lesions. Upon cessation of
chemotherapy, there was rapid re-growth in the primary
lesion, and the patient was admitted for surgery, in an
attempt to achieve local disease control. She underwent
radical mastectomy, axillary clearance and primary recon-
struction with a latissimus dorsi flap. Recovery was une-
ventful.
Histology described a large tumour (16 × 11 × 8 cm),
invading the breast and muscle, with extensive vascular
and lymphatic invasion and confirmed the diagnosis of
metaplastic breast carcinoma with osteogenic sarcoma
predominating. All sixteen lymph nodes removed were
involved. Surgical margins were at least 1 cm in all direc-
tions, and Paget's disease of the nipple was noted. The
tumour was negative for oestrogen and progesterone
receptors.
Two months later, she developed a new mass in the infra-
axillary region on the right, which rapidly enlarged. She
was given palliative chemotherapy with etopiside and car-
boplatin, during which she was admitted with neutro-
penic sepsis, from which she recovered. She was, however,
re-admitted three weeks later with deterioration in her
condition, and died in hospital a week later. The time
from first presentation to her death was almost exactly
eight months.
Discussion
The presentation of malignancy as a breast abscess is well
described [3], however, to our knowledge, this is the first
reported case of MBC presenting in this way.
MBC is a very rare neoplasm. 3 recently published series
over 13, 11 and 16 years yielded only 21, 19 and 43
patients respectively [4-6]. Even these have conflicting
conclusions regarding the most important prognostic
indicators and treatment options. Gibson et al [4] say that
MBC tends to present in an advanced stage and often
recurs locally, but survival is similar to that of adenocarci-
nomas of comparable stage, and hence treatment should
follow similar principles. Al Sayed et al [5], however, state
that MBC is aggressive with a poor outcome. They also
found that an important factor in determining outcome is
tumour size.
The mesenchymal element involved would seem to be
important in determining outcome [2]. In the case
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described, this was osteogenic sarcoma (OS). Pure extra-
osseous OS is an extremely rare neoplasm. In fact, one of
the largest series described only sixty cases over forty years
[7]. Of these, only 27% were sited in the trunk or thorax.
Most patients with OS of the breast invariably present
with a breast lump.
Extra-osseous OS differs from primary bone osteosarcoma
importantly in its response to chemotherapy. Complete
pathologic response rates of 25–60% are achievable for
bone osteosarcoma, however with extra-osseous OS
response rates are only 19% at best [8].
The prognosis for pure extra-osseous OS is similar to other
forms of high-grade soft tissue sarcoma. Those with
metastases at the time of diagnosis have a median survival
of only eight months, with a disease-specific 5-year sur-
vival of only 10% [7].
Conclusion
Metaplastic carcinoma of the breast is an extremely rare
malignancy, which, to our knowledge, has never before
been reported as presenting as a breast abscess. As pure
extra-osseous osteogenic sarcoma is much more chemore-
sistant compared with primary bone osteosarcoma, one
can surmise that metaplastic carcinomas with a predomi-
nating OS element will behave similarly indicating that
treatment options are limited.
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